TOP 100 MAGAZINE

Paul Hakimata: Redefining Patient-Centered Cancer Care

​

Paul Hakimata, MSc, MBA, is a specialist in molecular genomics at the Memorial Cancer Institute, part of the Memorial Healthcare System, and designated Florida Cancer Center of Excellence, whose groundbreaking work is transforming cancer treatment delivery. For more than 25 years, he has pursued answers in genetics, molecular biology, and biotechnology, pairing those disciplines with skills in computer coding and healthcare administration. His career began in research, but after the devastating loss of his wife to cancer a decade ago, Paul shifted into the clinical side of medicine. There, he saw firsthand how fragmented systems and slow turnaround times were costing patients precious weeks—time many of them did not have.

 

Today, his relentless drive to improve workflows and integrate precision medicine across departments has led to innovations that are saving lives and reshaping the standard of care. This is the story of a scientist whose personal tragedy became a catalyst for systemic change, a fearless surgeon willing to listen, and a healthcare system that embraced innovation to better serve its patients.

 

Memorial Healthcare System: A Mission to Heal

 

Based in Hollywood, Florida, Memorial Healthcare System is one of the largest public, not-for-profit health systems in the U.S., employing over 17,000 staff across six hospitals with more than 2,260 beds. Founded in 1953, Memorial is known nationally for quality, safety, and patient satisfaction. Its mission—“Heal the body, mind, and spirit of those we touch”—is carried out through a vision of exceptional patient- and family-centered care, medical education, research, and innovation. It is within this environment that Paul’s strategies have flourished.

 

A Unique Approach to Genomics and Care

 

Paul’s perspective blends science and practicality. He begins with two guiding questions: How does this help the patient? and How can we make it faster and better? That philosophy led him to focus on precision medicine workflow improvements, breaking down silos that keep departments isolated. By integrating genetics, clinical practice, and technology, he reduces turnaround times, cuts costs, and improves outcomes.

 

While genetics is his trade, his MBA gave him a grasp of healthcare administration, helping him align scientific priorities with financial realities. His self-taught computer coding skills—developed out of necessity when IT support fell short—have allowed him to build tools that reduce errors, generate usable data, and together with optimizing and integrating the pre-analytical workflow move cancer patients into treatment about a month sooner than the old status quo.

 

Technology and Innovation

 

Paul’s background in computer coding grew from necessity and a problem-solving mindset he developed early in his career. Mentored by demanding researchers, he learned to anticipate problems and create solutions on the fly—skills that now drive his clinical innovations. His philosophy is simple: jump in, solve the problem, and fine-tune along the way. This approach has sparked a “snowball effect” of tools and strategies that continually improve patient care.

 

A Journey of Science and Purpose

 

Born and raised in The Netherlands, Paul was an average student in subjects requiring memorization but excelled effortlessly in logic-based disciplines such as math, biology, and physics. Initially drawn to surgery, he pivoted toward laboratory science and microbiology, where he discovered the emerging field of genetics in the early 1990s.

 

Internships and research roles took him from the University of Pennsylvania to the University of Miami, Rockefeller University in New York, and Emory University in Atlanta, where he deepened his expertise in genetic engineering and laboratory management. Throughout his career, cancer research remained a constant interest, but the death of his wife from cancer shifted his focus toward the clinical arena. There, he resolved to confront the inefficiencies of healthcare systems and to use his knowledge to shorten the gap between diagnosis and treatment.

 

A Surgeon Who Listened

 

The turning point came during a tumor board at Memorial Cancer Institute. Discussing a lung cancer case, physicians noted that while they could recommend targeted therapies, they were always delayed by the wait for genetic data. For many patients, this waiting period was the difference between treatment and death.

 

Paul saw a simple solution: ask the surgeon to take an extra specimen during the procedure and send it immediately for genetic testing. The idea required no additional time nor cost, but it would cut weeks off the process. When he proposed it, one surgeon said yes.

 

That small act of listening launched a systemic shift. Today, Memorial averages genetic results within 8–9 days of surgery, delivered around the same time when the diagnosis is available, compared to an added 2- or 3-weeks industry norm. Patients can begin targeted therapies sooner, reducing ER visits and hospital stays while improving quality of life. What began as a five-minute conversation is now evolving into a standard of care, first for lung cancers and, soon, for other cancers as well.

 

Professional Accomplishments

 

Over the course of his career, Paul has developed Excel and Python coding tools that streamline workflows, reduce errors, and generate usable data from specimens once considered inadequate. These innovations have cut cancer treatment timelines by nearly a month, giving patients faster access to life-saving therapies. He has also secured grant funding that elevated Memorial Cancer Institute’s research and innovation profile, while advancing process improvement initiatives that showcase how precision medicine, technology, and cross-departmental collaboration can come together to redefine patient care.

 

The Road Ahead

 

Paul Hakimata’s story is one of resilience, innovation, and patient-centered purpose. From his early days in microbiology labs to his current role at Memorial Healthcare System, his journey reflects a commitment to breaking barriers between science and care.

 

With Memorial’s support and the collaboration of forward-thinking surgeons and physicians, his vision is becoming reality: precision medicine delivered faster, workflows aligned across departments, and patients receiving care that is not only advanced but compassionate. For Paul, the North Star remains clear—every innovation must lead back to the patient.

​

 

Paul Hakimata, MSc, MBA
Specialist Molecular Genomics
Memorial Healthcare System
LinkedIn: www.linkedin.com/in/phakimpour